Safety of corticosteroids and immunosuppressive agents in ulcerative colitis.
For many years, corticosteroids have been the mainstay for treating acute ulcerative colitis. In patients with refractory disease, immunosuppressive therapy may be indicated, including azathioprine or its metabolite 6-mercaptopurine, cyclosporin and possibly methotrexate. Their benefits in ulcerative colitis must be weighed up against their possible adverse effects, the availability of surgical cure for this condition, and the long-term risk of carcinoma complicating colitis that applies in patients with chronic extensive disease. Information about the safety of corticosteroids and immunosuppressive agents has accumulated as a result of their extensive use in inflammatory bowel disease, organ transplantation and various other disorders.
Connell
W R
WR
Department of Gastroenterology, St Vincent's Hospital, Fitzroy, Victoria, Australia.
Taylor
A C
AC
D003093:Colitis, Ulcerative / Q000188:drug therapy*; D005938:Glucocorticoids / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D012074:Remission Induction / Q000379:methods; D012449:Safety; D016896:Treatment Outcome
D005938:Glucocorticoids; D007166:Immunosuppressive Agents